TABLE 2

Association Between Sex, Uropathogen Type, and Etiology of Neurogenic Bladder and Pyuria

PredictorsCultures ≥10 000 CFU/mLCultures ≥100 000 CFU/mL
Odds of Pyuria95% CIOdds of Pyuria95% CI
Sex
 FemaleReferenceReference
 Male1.69a(1.32–2.16)a1.70a(1.29–2.26)a
Uropathogen
E coliReferenceReference
P aeruginosa1.00(0.63–1.61)0.86(0.48–1.59)
Staphylococcus saprophyticus0.93(0.13–18.60)bb
Enterococcus species0.66a(0.47–0.91)a0.44a(0.30–0.64)a
Klebsiella species0.95(0.67–1.36)0.81(0.54–1.20)
Proteus species1.74(0.93–3.56)2.16a(1.05–5.03)a
Enterobacter species1.39(0.77–2.66)0.94(0.53–1.73)
 Other0.86(0.63–1.17)0.83(0.58–1.19)
Etiology of neurogenic bladder
 MyelomeningoceleReferenceReference
 Anorectal malformation0.94(0.63–1.43)1.16(0.72–1.92)
 Tethered cord1.22(0.79–1.91)1.67a(1.02–2.83)a
 Bladder exstrophy3.24(0.95–20.28)3.46(0.97–22.16)
 Cloacal malformation1.09(0.71–1.70)1.84a(1.04–3.42)a
 Spinal cord injury0.98(0.38–3.06)2.95(1.09–10.3)
 Eagle-Barrett syndrome1.61(0.45–10.28)bb
 Other0.76a(0.59–0.98)a1.02(0.77–1.35)
Presence of mitrofanoff2.41a(1.81–3.24)a3.14a(2.19–4.63)a
Presence of hydronephrosis1.01(0.51–2.21)1.22(0.51–3.42)
Presence of VUR2.20a(1.63–3.24)a4.55a(3.07–6.98)a
  • —, not applicable.

  • a Indicates statistical significance.

  • b CI unable to be computed because of a small sample size.